RSPH10B Activators
RSPH10B activators refer to a class of chemical compounds that modulate the activity of the RSPH10B gene product. RSPH10B, also known as Radial Spoke Head 10 Homolog B, is a gene that is known to encode a protein component of the radial spoke, which is a complex assembly within the structure of cilia and flagella. Cilia and flagella are hair-like structures that protrude from the surface of many eukaryotic cells; they are critical for a variety of cellular processes including motility, sensory perception, and signal transduction. The radial spokes are key to the regulation of the dynein arms and are thus integral to the proper bending and movement of these cellular appendages. RSPH10B activators, therefore, are chemicals that interact at the molecular level to enhance the function of the protein encoded by RSPH10B, potentially affecting the dynamics of cilia and flagella movement.
Chemically, RSPH10B activators can be diverse, encompassing small molecules, peptides, or other bioactive compounds that have the ability to interact with the RSPH10B protein or its regulatory pathways. These interactions can occur through various mechanisms, such as direct binding to the protein, influencing the transcription or translation of the RSPH10B gene, or stabilizing the protein and protecting it from degradation. The precise molecular architecture of these activators is typically designed or discovered through extensive biochemical and structural analysis, aimed at achieving specificity and potency in their activity. Understanding the structural biology of RSPH10B and the cellular mechanisms governing cilia and flagella function is essential for the rational design of these activators. The effects of RSPH10B activators, at a cellular level, could lead to alterations in the motility patterns of cilia and flagella, which may have significant consequences for the cellular functions that rely on these organelles.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine and beta-adrenergic agonist that increases intracellular cAMP levels. By elevating cAMP, it can activate PKA which in turn could phosphorylate targets within the signaling pathways that RSPH10B is involved in, leading to its activation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a diterpene that activates adenylate cyclase, increasing cAMP levels in the cell. The rise in cAMP can activate PKA, which may indirectly enhance the activity of RSPH10B through phosphorylation of proteins within RSPH10B-related pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can phosphorylate a wide range of target proteins. Activation of PKC can modulate signaling pathways that indirectly lead to the activation of RSPH10B by altering its interaction environment. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent kinases and phosphatases. This modulation in calcium signaling could impact pathways where RSPH10B is active and lead to its functional enhancement. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. Activated PKA can phosphorylate proteins within signaling pathways that RSPH10B is part of, possibly enhancing the functional activity of RSPH10B. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is another cell-permeable cAMP analog that activates PKA, similar to 8-Bromo-cAMP. By activating PKA, it can indirectly lead to the activation of RSPH10B by influencing proteins and pathways that interact with RSPH10B. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which breaks down cAMP. By inhibiting PDE4, rolipram increases intracellular cAMP levels, potentially enhancing PKA activity and indirectly activating RSPH10B through cAMP-dependent pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore similar to ionomycin, raising intracellular calcium levels. The increase in calcium can lead to the activation of calcium-dependent signaling pathways, which could influence the activity of RSPH10B indirectly. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that could lead to the activation of RSPH10B by inhibiting competing tyrosine kinase pathways. This allows for a shift in cellular signaling that may favor pathways associated with the functional activity of RSPH10B. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters AKT signaling and other downstream pathways. By modulating the PI3K/AKT pathway, LY294002 can influence cellular processes and signaling cascades that may enhance the activity of RSPH10B. | ||||||